Success Stories: NAILG Demonstrates Expertise in Securing NIW Approval for a Senior Scientist in Biochemistry

Posted by wegreened on October 16, 2025 in NIW, Chemistry (Organic Chemistry, Biochemistry, Biochemical Engineering, Electrochemical Engineering, Physical Chemistry, Macromolecular Engineering, Polymer Chemistry, Chemical Engineering)

Client’s Testimonial:

“Thank you so much for your help with my case!”

On February 25^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Senior Scientist

Country of Origin: China

State of Residence at the Time of Filing: Maryland

Approval Notice Date: February 27^th, 2025

Processing Time: 9 months, 22 days

Case Summary:

Cancer remains the second leading cause of death worldwide, with therapeutic resistance and metastasis continuing to undermine treatment effectiveness and survival rates. Beyond cancer, infectious and immune-related diseases still impose a heavy burden on public health. Meeting these challenges requires innovative therapeutic solutions, an urgent national priority that North America Immigration Law Group (NAILG) was proud to champion in securing an EB-2 NIW approval for a biochemistry researcher whose work is reshaping the future of treatment.

Our client has developed engineering approaches for the production of therapeutic antibodies and novel antibody-like proteins designed to improve clinical outcomes in oncology, immunology, and anti-infection applications. Her innovations not only provide clinicians with more effective tools to overcome therapeutic resistance and metastasis but also enhance production efficiency to ensure broader accessibility of life-saving treatments. By creating technologies that strengthen both efficacy and availability, she is helping to transform the therapeutic landscape in ways that directly benefit patients and strengthen the healthcare system.

Her record of achievement demonstrates both innovation and recognition at the international level:

4 peer-reviewed journal articles, 2 first-authored conference abstracts, 1 first-authored book chapter.
1 international patent application publication.
127 citations of her published work.
Funding support from the National Science Foundation Division of Chemistry (NSF CHE) and the National Institutes of Health (NIH).

Her peers have highlighted the irreplaceable value of her contributions: "To sum up, [Client]'s skillset is irreplaceable, given its immense benefits to pharmaceutical drug development, cancer therapeutics, protein interaction targeting, peptide-based medicine advancement, immunotherapy innovation, and novel antibody alternatives. It is imperative that she be allowed to carry out her research uninterrupted so that the US is able to benefit fully from its value."

By strategically framing her accomplishments, patent activity, and federal funding support, NAILG prepared a persuasive petition that emphasized the dual importance of her work, advancing clinical care while bolstering U.S. biomedical competitiveness. This approach ensured USCIS recognized the national significance of her proposed endeavor, resulting in NIW approval and paving the way for her continued contributions to therapeutic innovation in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%